Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TBXAS1 | P24557 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.41 |
| ▸ | RNPEP | Q9H4A4 | 1/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | PPARD | Q03181 | 1/20 | 0.39 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.39 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | GSR | P00390 | 1/20 | 0.37 |
| ▸ | CPB2 | Q96IY4 | 2/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.37 |
| ▸ | NOS2 | P35228 | 1/20 | 0.36 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9620650 | 1.00 | TBXAS1 (0.52) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL9620658 | 1.00 | TBXAS1 (0.52) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL9183195 | 1.00 | TBXAS1 (0.52) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL688373 | 1.00 | TBXAS1 (0.52) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL5844804 | 1.00 | TBXAS1 (0.52) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL689688 | 1.00 | TBXAS1 (0.52) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL5844802 | 0.97 | TBXAS1 (0.48) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL628995 | 0.91 | LMNA (0.44) | TBXAS1LMNAGPR84RNPEPALDH1A1 | |
| SCHEMBL27413119 | 0.90 | TBXAS1 (0.46) | TBXAS1LMNAGPR84RNPEPFFAR1 | |
| SCHEMBL11753554 | 0.90 | TBXAS1 (0.46) | TBXAS1LMNAGPR84RNPEPFFAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2128122-B1 | PROCESS FOR PRODUCING CARBOXYLIC ACID CHLORIDE | MITSUI CHEMICALS INC (JP) | 2014-01-22 | — | — | EP | disclosed |
| US-8222446-B2 | Method for producing dihydroxybenzene derivative | MITSUI CHEMICALS, INC. (JP) | 2012-07-17 | — | — | US | disclosed |
| US-8198482-B2 | Method for producing carboxylic acid chloride | MITSUI CHEMICALS, INC. (JP) | 2012-06-12 | — | — | US | disclosed |
| EP-1820667-B1 | PNEUMATIC TIRE | BRIDGESTONE CORP (JP) | 2012-02-29 | — | — | EP | disclosed |
| US-20110004013-A1 | METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE | MITSUI CHEMICALS, INC. (JP) | 2011-01-06 | — | — | US | disclosed |
| EP-2269976-A1 | PROCESS FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE | Mitsui Chemicals, Inc. (JP) | 2011-01-05 | — | — | EP | disclosed |
| US-7823614-B2 | Pneumatic tire | BRIDGESTONE CORPORATION (JP) | 2010-11-02 | — | — | US | disclosed |
| US-20100099911-A1 | METHOD FOR PRODUCING CARBOXYLIC ACID CHLORIDE | MITSUI CHEMICALS, INC (JP) | 2010-04-22 | — | — | US | disclosed |
| EP-2128122-A1 | PROCESS FOR PRODUCING CARBOXYLIC ACID CHLORIDE | Mitsui Chemicals, Inc. (JP) | 2009-12-02 | — | — | EP | disclosed |
| US-20090229728-A1 | PNEUMATIC TIRE | BRIDGESTONE CORPORATION (JP) | 2009-09-17 | — | — | US | disclosed |
| EP-1820667-A1 | PNEUMATIC TIRE | Bridgestone Corporation (JP) | 2007-08-22 | — | — | EP | disclosed |
| US-5424349-A | Tertiary amides with low volatility and good thermal stability | ALBEMARLE CORPORATION (US) | 1995-06-13 | — | — | US | disclosed |
| WO-1992016495-A1 | AMIDE ANTIOXIDANTS | ETHYL CORPORATION (US) | 1992-10-01 | — | — | WO | disclosed |
| EP-0279978-B1 | PHARMACEUTICAL COMPOSITIONS CONTAINING ALPHA-HALOGENATED DICARBOXYLIC ACIDS | Epis S.A. (CH) | 1992-01-02 | — | — | EP | disclosed |
| US-4908385-A | Pharmaceuticals | EPIS S.A. (CH) | 1990-03-13 | — | — | US | disclosed |
| EP-0279978-A1 | Pharmaceutical compositions containing alpha-halogenated dicarboxylic acids | Epis S.A. (CH) | 1988-08-31 | — | — | EP | disclosed |
| WO-1988002746-A1 | MEDICAMENTS CONTAINING ALPHA-HALOGENATED DICARBOXYLIC ACIDS | EPIS S.A. (CH) | 1988-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110004013-A1 | METHOD FOR PRODUCING DIHYDROXYBENZENE DERIVATIVE | UBE2B, UBE2G2, TUBB2B | TBXAS1 2114/4885LMNA 3340/4885GPR84 933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.